SHAUN COOK: Open Payments
NPI 1134675531 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,717 in 90 payments from 20 companies in 2025. Trend: 2023 $1,469 · 2024 $1,676 · 2025 $1,717
Food & beverage: $1,617Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 27 | $297 |
| Grifols USA, LLC | 7 | $211 |
| GENZYME CORPORATION | 5 | $167 |
| Insmed, Inc. | 7 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $138 |
| Merck Sharp & Dohme LLC | 5 | $119 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Prolastin-C Liquid, Arikayce, WINREVAIR, AIRSUPRA, JASCAYD, NUCALA.
Industry payments across GA — which companies pay providers there.
